What does CUSIP 68827R108 represent in this 13F holders report?

CUSIP 68827R108 is the security identifier for OSIR - OSIRIS THERAPEUTICS INC NEW - COM used to aggregate holder disclosures.

How many institutions held OSIR - OSIRIS THERAPEUTICS INC NEW - COM in Q2 2013?

3 institutional investors reported OSIR - OSIRIS THERAPEUTICS INC NEW - COM for Q2 2013. Use the holders table for investor-level position and value details.

OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q2 2013 13F Holders as of 30 Jun 2013

Type / Class: Equity / COM
Total 13F shares: 108,050
Share change: 0
Total reported value: $1,089,000
Price per share: $10.07
Number of holders: 3

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2013
Previous quarter: Q1 2013

Recent filing periods for CUSIP 68827R108:

Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q2 2013

As of 30 Jun 2013, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 108,050 shares. The largest 3 holders included HUNTINGTON ASSET ADVISORS, INC., CITADEL ADVISORS LLC, and WELLS FARGO & COMPANY/MN. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.